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doi:10.1016/j.jtcvs.2007.12.01294 The Journal of Thoracic and CardiObjective: The risk of death during the interstage period remains high after stage 1
reconstruction for single ventricle lesions, despite improved surgical results. The pur-
pose of this study is to identify risk factors for interstage death and to describe the
events leading to interstage death.
Methods: A nested case–control study was conducted of 368 patients who underwent
stage 1 reconstruction at a single center between January 1998 and April 2005.
Results: Among the 313 (85%) hospital survivors, there were 33 (10.5%) interstage
deaths. Cases more frequently presented with intact or restrictive atrial septum (9
[27%] vs 4 [4%]; P , .001), were older at the time of surgery (5 [2–40] vs 3 [1–
42] days; P 5 .005), had more postoperative arrhythmias (12 [36%] vs 15 [15%];
P 5 .01), and a higher incidence of airway or respiratory complications (12 [36%]
vs 19 [19%]; P5 .04). By multivariate analysis, only intact atrial septum (odds ratio
7.6; 95% confidence intervals 1.9–29.6; P 5 .003) and age at operation greater than
7 days (odds ratio 3.8; 95% confidence intervals 1.3–11.2; P5 .017) were predictors
of interstage death.
Conclusions: The presence of intact atrial septum and older age at the time of surgery
are associated with a higher risk of interstage death. In addition, postoperative arrhyth-
mia and airway complications are associated with a higher risk of interstage death in
univariate analysis. The results of this study provide a focus for interstage monitoring
and risk stratification of these high-risk infants, which may improve overall survival.
H
ypoplastic left heart syndrome (HLHS) and its variants present unique man-
agement challenges to the cardiac intensive care team after stage 1 recon-
struction (S1R). Equally challenging is the prevention of interstage death
(ISD), defined as death after hospital discharge and before admission for a planned
stage 2 reconstruction (S2R). Hospital survival after S1R has improved as a result
of continued innovation and refinement in surgical technique, earlier diagnosis and
referral to tertiary care centers, and advances in perioperative care.1-10 As a result,
this group of congenital lesions once considered universally fatal in infancy now
has a survival after S1R of 77% to 93%.11-16 However, at most centers ISD rates
are unchanged from historical rates of 7% to 15%.17-22 Therefore, interstage mortality
constitutes an increasing percentage of overall mortality in the current era and is
attracting increased clinical and research attention.
The reported causes of ISD range from simple intercurrent illnesses to catastrophic
shunt thromboses.19,23 In attempts to identify those patients at risk for ISD events, past
investigators have identified residual anatomic lesions, depressed myocardial function,
elevated systemic vascular resistance, arrhythmia, and noncardiac factors such as sei-
zures and feeding dysfunction as significant risk factors.3,12,19-25 It is clear that afterovascular Surgery c July 2008
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DAbbreviations and Acronyms
CI 5 confidence interval
ISD 5 interstage death
OR 5 odds ratio
S1R, S2R 5 stage 1 reconstruction, stage 2 reconstruction
S1R, many patients with single ventricle physiology have
fragile hemodynamics and at times do not tolerate even minor
stressors. Therefore, management strategies have focused on
creating a more stable circulation through surgical and med-
ical advances as well as identifying and better monitoring
those patients at high risk for ISD. The goal of this study is
to identify those patients who are at high risk for ISD, with
a secondary goal of describing the events leading to ISD.
Patients and Methods
Study Design
We performed a retrospective case–control study including all
patients who underwent S1R at the Children’s Hospital of Philadel-
phia from January 1998 to August 2005. The study was approved by
the Institutional Review Board (IRB No. 2004-10-2890); informed
consent was waived. Hospital medical records, the Cardiac Center
database systems, and outpatient cardiology records were reviewed
to identify ISD and control patients. For study patients, additional
data reviewed included echocardiography reports, cardiac catheter-
ization reports, and operative reports, including extramural reports
when appropriate. Outpatient cardiologists were contacted for
follow-up information when necessary. For each case, 3 controls
were randomly chosen from the cohort of patients who had under-
gone surgery within the same calendar year as the case and had
survived to S2R.
Definitions
Patients who died before hospital discharge are designated as hospi-
tal deaths. Hospital deaths include patients transferred to referring
hospitals who died before discharge from those units. For those pa-
tients transferred to a referring hospital, the transfer date was used
for calculating length of stay. Inoperable patients were those not re-
ferred for S2R within 1 year of S1R owing to unsuitability for further
palliation. Transplanted patients were those who underwent S1R but
subsequently underwent transplantation before S2R. Hospital
deaths, inoperable patients, and transplanted patients were excluded
from the control group.
Anatomy and Patient-related Factors
All patients underwent S1R for lesions consisting of a single func-
tional ventricle with obstruction to systemic outflow (Table 1). An-
atomic diagnoses were established from echocardiography reports,
cardiac catheterization reports, surgical notes, and autopsy reports.
In cases of a disputed diagnosis, operative reports and autopsy
reports were given precedence. The diagnosis of intact atrial septum
was based on echocardiography or catheterization findings of absent
atrial communication. Highly restrictive atrial septum was defined
as an atrial septal defect measuring less than 2 mm and a restrictive
Doppler flow pattern.26The Journal of ThOperative Technique
The standard S1R performed at our institution during the study
period consisted of an atrial septectomy, division of the main pulmo-
nary artery with side-to-side anastomosis to the ascending aorta, or
homograft patch augmentation of the ascending aorta and aortic
arch, with either a modified Blalock–Taussig shunt or a right ven-
tricular–pulmonary artery conduit as the source of pulmonary blood
flow.12 From 1998 to 2002, the modified Blalock–Taussig shunt was
used exclusively, whereas from 2002 to 2005 there was contempo-
rary use of both shunt types. Five surgeons performed S1R during
this period. Repair of additional intracardiac lesions was undertaken
simultaneously where appropriate. Modified ultrafiltration was
routinely used. In the postoperative period, neither delayed sternal
closure nor extracorporeal membrane oxygenation was routinely
used. The usual postoperative care during this time period included
infusions of milrinone, dopamine, and fentanyl, normal ventilation,
normothermia, and discontinuation of neuromuscular blockade the
first postoperative night.
Data Analysis
Demographic data, operative factors, and postoperative events were
recorded. Continuous variables are presented as mean (6 standard
deviation) for normally distributed data and median (range) for non-
normally distributed data. Dichotomous variables are presented as
count and percent. Categorical data were compared by the Fisher ex-
act test or c2 test where appropriate. For comparison of continuous
variables between cases and controls, a Student t test was used for
normally distributed data and a Wilcoxon rank sum test otherwise.
An a priori significance level of a5 .05 was used. Stepwise logistic
regression using backward selection was performed to identify inde-
pendent risk factors found to be significant from univariate analysis.
Analysis was performed with STATA 8.0 (STATA Corporation
2003, College Station, Tex).
Main Results
During the study period, there were 33 (10.5%) ISDs (Figure E1). Of
the original cohort of 368 patients, 263 (71%) went on to S2R, from
which the control group was taken.
Risk Factors for ISD
Preoperative demographic and cardiac features analyzed are shown
in Table 2. Patients with an intact or highly restrictive atrial septum
TABLE 1. Preoperative anatomy: Subclass and variants
Category
Cases
(n 5 33)
Controls
(n 5 99) P
HLHS (all) 25 (76%) 64 (65%) .20
With aortic atresia 17 (52%) 44 (44%) .48
HLHS variants
Complex double-outlet right ventricle 0 9 (9%) .11
Unbalanced atrioventricular canal 5 (15%) 9 (9%) .33
Other* 3 (9%) 17 (17%) .26
*Other includes double-inlet left ventricle with transposition of the great ar-
teries (TGA) and systemic outflow obstruction, tricuspid atresia with TGA
and systemic outflow obstruction, TGA with inadequate systemic ventricle
and systemic outflow obstruction, and critical aortic stenosis/aortic hypo-
plasia with inadequate systemic ventricle.oracic and Cardiovascular Surgery c Volume 136, Number 1 95
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Dwere at significantly higher risk of ISD (9 [27%] cases vs 4 [4%] con-
trols; P, .001). A single morphologically left ventricle was protec-
tive (0 cases vs 14 [14%] controls; P 5 .02). No other preoperative
anatomic or functional cardiac factor was found to be significant.
Among the patient demographic preoperative variables analyzed,
only age at the time of operation was found to be significant:
5 days (2–40) in cases versus 3 days (1–42) in controls (P 5 .005).
No difference was found in any operative factor analyzed (Table
3). Of the postoperative factors evaluated (Table 4), airway or res-
piratory anomalies or respiratory complications were more common
in cases (12 cases [36%] vs 19 controls [19%]; P 5 .04), and post-
operative arrhythmias necessitating an intervention were more fre-
quently documented in cases (12 cases [36%] vs 15 controls
[15%]; P 5 .01). Of the cases with a significant postoperative
TABLE 2. Preoperative variables: Demographics and
cardiac features
Variable
Cases
(n 5 33)
Controls
(n 5 99) P
Gender (% male) 19 (57%) 66 (67%) .35
Birth weight (kg) 3.0 (1.5–4.2) 3.2 (1.6–4.5) .43
Gestational age (wk) 40 (30–41) 39 (31–41) .28
Age at time of surgery (d) 5 (2–40) 3 (1–42) .005
Age at surgery . 7 d 10 (30%) 10 (10%) .006
Birth weight , 2.5 kg 6 (18%) 15 (15%) .68
Born remote to surgical center 14 (42%) 50 (50%) .42
Prenatal diagnosis 15 (45%) 61 (62%) .11
Syndromes and major malformations
Major noncardiac anomaly 7 (21%) 16 (16%) .5
Heterotaxy syndrome 3 (9%) 4 (4%) .37
Cardiac variables
Single left ventricle 0 14 (14%) .02
Intact or highly restrictive
atrial septum
9 (27%) 4 (4%) ,.001
Preoperative AV valvular
insufficiency*
7 (21%) 14 (14%) .34
AV, Atrioventricular. *Preoperative AV valvular insufficiency rated as mod-
erate or greater by echocardiography.
TABLE 3. Operative variables
Variable
Cases
(n 5 33)
Controls
(n 5 99) P
Operative times (mean 6 SD)
Cardiopulmonary bypass time (min) 96 6 34 95 6 26 .85
Circulatory arrest time (min) 44 6 13 46 6 16 .63
Shunt type: RV–PA 3 (9%) 14 (14%) .45
Delayed sternal closure 6 (18%) 14 (14%) .58
Postoperative ECMO 2 (6%) 1 (1%) .15
Surgical revision* 1 (3%) 6 (6%) .68
SD, Standard deviation RV–PA, right ventricle–pulmonary artery conduit;
ECMO, extracorporeal membrane oxygenation. Surgical revision, *revision
of S1R within the same admission.96 The Journal of Thoracic and Cardiovascular Surgery c Julyarrhythmia, 4 had a re-entrant supraventricular tachycardia, 3 junc-
tional ectopic tachycardia, 2 ectopic atrial arrhythmias and frequent
atrial ectopy, and 2 ventricular tachycardia. One patient had high-
grade heart block that resolved before discharge. Cardiac status at
the time of discharge was no different between the groups, as eval-
uated by echocardiographic features, need for oxygen, and number
of medications.
Multivariate logistic regression revealed intact or highly
restrictive atrial septum (odds ratio [OR] 7.6; 95% confidence inter-
vals [CI] 1.9–29.6; P 5 .003) and age at operation greater than
7 days (OR 3.8; 95% CI 1.3–11.2; P 5 .017) to be independent
risk factors for ISD.
Circumstances of ISD
The circumstances of ISD events are detailed in Table 5. Death
occurred at a median of 64 (18–257) days of age. The median
time from discharge to ISD was 44 (2–188) days. Fourteen (42%)
ISD patients experienced sudden, unexpected deaths at home. Inter-
estingly, 11 (33%) patients died during a subsequent hospitalization.
Of these, 4 died after a procedure (Nissen fundoplication, gastro-
stomy tube manipulation, shunt revision, and cardiac catheteriza-
tion). The remainder were hospitalized with a wide range of
diagnoses, including respiratory insufficiency and/or infections (n
5 4), severe cardiac dysfunction (n 5 2), and feeding dysfunction
(n 5 1). In 8 patients, information regarding the ISD event was
not obtained. Autopsy results were available for 8 patients (Table E1).
TABLE 4. Postoperative variables
Variable
Cases
(n 5 33)
Controls
(n 5 99) P
Postoperative arrhythmia 12 (36%) 15 (15%) .01
Postoperative arrest* 2 (6%) 1 (1%) .15
Airway and respiratory:
Need for reintubation 10 (30%) 17 (17%) .11
Vocal cord paresis 4 (12%) 4 (4%) .11
Diaphragm paresis 0 3 (3%) .57
Tracheostomy 2 (6%) 2 (2%) .26
Any airway complicationy 12 (36%) 19 (19%) .04
Nasogastric feeding at discharge 14 (42%) 49 (49%) .48
Surgical gastric tube 5 (15%) 7 (7%) .16
Postoperative seizure 6 (18%) 9 (9%) .15
Abnormal MRI 10 (30%) 22 (22%) .35
ECHO measures at discharge
Ventricular dysfunctionz 0 3 (3%) .57
Residual coarctation 1 (3%) 3 (3%) 1
AV valvular insufficiencyx 10 (30%) 20 (20%) .23
Neoaortic insufficiencyjj 4 (12%) 4 (4%) .11
On oxygen at discharge 8 (24%) 15 (15%) .23
Discharge on . 3 medications 20 (60%) 41 (41%) .06
MRI,Magnetic resonance imaging; ECHO, echocardiographic; AV, atrioven-
tricular. *Postoperative arrest requiring cardiopulmonary resuscitation
including chest compressions. yAny airway complication: need for reintuba-
tion or vocal cord paresis or diaphragm paresis or trachesostomy.
zVentricular dysfunction rated at moderate or greater. xAV valvular insuffi-
ciency rated at moderate or greater. jjNeoaortic insufficiency rated mild or
greater.2008
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Patient
Age at
OR (days)
Age at
ISD (days) Circumstances of ISD Known risk factors at discharge*
1 2 104 Unknown None
2 15 31 Observed emesis and arrest in hospital; GER VCP
3 4 18 Sudden death at home; cyanosis on O2 None
4 5 165 Died after G-tube exchange; severe TR IAS; arrhythmia; failed extubation
5 3 NA Sudden death at home IAS; arrhythmia
6 5 51 Sudden death at home None
7 2 31 Respiratory arrest; readmitted for CRI Tracheostomy; failed extubation
8 2 125 Unknown None
9 12 23 Unknown Arrhythmia
10 5 140 Readmitted with PHTN; DNR Arrhythmia; failed extubation
11 2 49 ICU arrest; readmitted with severe dysfunction None
12 3 115 Sudden death at home; severe TR Arrhythmia; failed extubation
13 2 96 Sudden death at home; recent C. diff admission VCP; failed extubation
14 3 73 Sudden death at home Failed extubation
15 4 57 Sudden death at home IAS; arrhythmia; failed extubation
16 7 59 ICU arrest; RSV; interim stent for IAS None
17 10 48 ICU arrest: aspiration pneumonia None
18 40 135 Sudden death at home; likely BTS occlusion IAS; arrhythmia
19 5 62 Died due to complications from Nissen None
20 6 120 Sudden death at home associated with fever None
21 3 78 Died after shunt revision. Died during readmission
for shunt revision
None
22 7 38 Unknown None
23 4 27 Sudden death at home; declining cardiac function Arrhythmia
24 22 257 Unknown Arrhythmia; tracheostomy
25 22 104 Died after complications of catheterization None
26 5 64 Unknown IAS
27 8 120 Sudden death at home; diarrhea, dehydration IAS; arrhythmia
28 13 142 Sudden death at home; progressive cyanosis VCP
29 8 62 Unknown None
30 12 NA Sudden death at home IAS; arrhythmia; failed extubation, VCP
31 4 71 Sudden death at home likely related to bacteremia Arrhythmia; failed extubation
32 4 59 Unknown IAS
33 4 142 Readmitted with URI; observed apnea in hospital None
OR, Operation; ISD, interstage death; GER, gastroesophageal reflux disease; VCP, vocal cord paresis; G-tube, surgical gastrostomy feeding tube; TR, tricuspid
regurgitation; IAS, intact or highly restrictive atrial septum; CRI, chronic respiratory insufficiency; PHTN, pulmonary hypertension; DNR, Do Not Resuscitate
order; C. diff, Clostridium difficile; BTS, Blalock–Taussig shunt; URI, upper respiratory infection. *Risk factors including: IAS; age at surgery. 7 days; arrhyth-
mia; airway/respiratory complications (failed extubation, vocal cord paresis, diaphragm paresis, or tracheostomy). ICU5 Intensive care unit; RSV 5 Respi-
ratory syncytial virus.One patient had a documented shunt thrombosis, and another had
evidence of diffuse thrombosis and emboli, but no occlusive throm-
bus in the shunt was found at the time of autopsy. In 3 patients there
was evidence of myocardial ischemia and infarction, 2 of whom had
significant involvement of the tricuspid apparatus. One patient had
polymicrobial bacteremia, possibly associated with bowel perfora-
tion and bacterial translocation. In 2 patients, the autopsy did not
suggest any cause of death.
Discussion
As recent advances have led to improved operative outcomes
in HLHS and its variants, we hope this study will advance the
development of management strategies to improve interstageThe Journal of Thooutcomes. In this cohort, restriction at the level of the atrial
septum and delayed time of surgery were found to be inde-
pendent risk factors for ISD. In addition, univariate analysis
found the occurrence of a perioperative arrhythmia or an
airway or respiratory complication more frequently in cases.
These modifiable risk factors provide intriguing targets for
future interventions in addition to guiding risk stratification
for the development of interstage monitoring protocols.
Patients with an intact or highly restrictive atrial septum
are at high risk for mortality at every stage of single ventricle
palliation, including the interstage period. These patients
have evidence of abnormal pulmonary vasculature from
birth, with ‘‘arterialization’’ of the pulmonary veins andracic and Cardiovascular Surgery c Volume 136, Number 1 97
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Ddilation of pulmonary lymphatics.26 As a result, they are
more likely to have elevated pulmonary arterial pressures
and are theoretically more susceptible to perturbations of pul-
monary and systemic vascular resistance associated with in-
terstage stressors. Recent research efforts have focused on
fetal intervention, using either early surgical or interventional
catheterization techniques to relieve the obstruction before
the development of pulmonary vascular disease.27 Whether
these interventions will positively affect outcomes remains
to be seen. It is unclear whether the administration of supple-
mental oxygen or other medications targeting the pulmonary
vascular bed in the interstage period would be beneficial in
this select patient population.
Delayed surgery in single ventricle lesions may occur
as the result of late presentation, prematurity or low birth
weight, presentation with multisystem organ dysfunction,
and in some centers after primary consideration for transplan-
tation. Past studies have shown that older age at time of pre-
sentation and at time of operation results in worse outcomes
in this population.21,26,27 In this study, we found that patients
older than 7 days at the time of operation were more likely to
have ISD. In most cases there is no advantage in delaying sur-
gery; however, individual patients have survived delayed
palliation, and in specific circumstances it may be necessary
to delay S1R.6 It is likely that this variable represents a marker
for level of illness at presentation in the current cohort: well
patients with no organ dysfunction are more likely to go to
the operating room promptly and have a favorable operative
and postoperative course.
Our finding that perioperative arrhythmia is more com-
monly identified in ISD patients agrees with previous stud-
ies.17,21 Of the 12 ISD patients identified with significant
postoperative arrhythmia, 9 (27%) were discharged receiving
a medication specifically to treat or prevent arrhythmia. Only
1 patient from the entire cohort had a documented arrhythmia
at the time of ISD and received cardioversion in the field for
wide complex tachycardia, without return of spontaneous cir-
culation. This patient was not among those known to have
a perioperative arrhythmia. Arrhythmia may explain a signif-
icant proportion of unexpected ISD but represents a difficult
target for retrospective study. Arrhythmia as a cause of death
cannot be diagnosed at autopsy, nor is rhythm at the time of
arrest always possible to ascertain in the field. Kaltman and
associates28 prospectively compared indices of heart rate var-
iability in infants who underwent single ventricle palliation to
those with 2-ventricle repairs of various congenital lesions.
The authors demonstrated a significant reduction in heart
rate variability and a higher baseline heart rate during the vul-
nerable period for ISD in these patients.
The causes of death in this series were varied, and no
previously unrecognized residual technical issues were
identified on autopsy. In an autopsy series of 122 deaths after
S1R from 1980 to 1995, Bartram, Grunenfelder, and Van
Praagh23 concluded that, in their series, most deaths were98 The Journal of Thoracic and Cardiovascular Surgery c Julyattributable to potentially correctable residual technical
issues. Data from our institution and other large centers
demonstrate that many of these technical issues have been
eliminated or substantially improved on in the current
era.11-15,21 Therefore, causes of ISD that previously consti-
tuted a smaller proportion of total post-S1R mortality (eg,
arrhythmia, shunt thrombosis, viral infections) have become
more prevalent. Fenton and coworkers19 described a series of
patients with shunt-dependent pulmonary blood flow who
had ISD and found that autopsy-proven shunt thrombosis oc-
curred in 33% of these patients. Other retrospective clinical
studies have found the rate of shunt thrombosis to be from
8% to 16%,1,3,13 whereas in our experience only 6% of
ISDs were associated with possible shunt thrombosis on
autopsy. Interestingly, Fenton’s group19 found no difference
in the incidence of ISD or shunt thrombosis in patients taking
aspirin and those receiving no anticoagulation. The ideal anti-
coagulation strategy remains an important area of discussion
at every stage of single ventricle palliation.
High systemic afterload may play a significant role in the
pathogenesis of unexpected ISD in this population. Recent
studies have highlighted the important role of afterload
reduction in postoperative care and long-term manage-
ment.3,8,25 In addition, there is mounting evidence that auto-
nomic function is altered after cardiac surgery,28 which may
further impair the ability of these patients to compensate for
wide swings in systemic vascular resistance associated with
intercurrent illnesses and other interstage stressors. In this
cohort, patients with significant atrioventricular valvular re-
gurgitation or ventricular dysfunction in the postoperative
period were frequently prescribed captopril, but oral afterload
reduction was not routine.
It is unlikely that a single surgical or medical intervention
will significantly improve current ISD rates owing to the het-
erogeneous nature of ISD events. It may be more effective to
focus our attention during the interstage period on identifying
those most at risk, increasing and standardizing surveillance,
and investigating subtle abnormalities earlier. In a study
using an intensive multidisciplinary interstage monitoring
program, Ghanayem and associates20 demonstrated an im-
provement in the ISD rate from 15.8% to 0% during the study
period. At the time of discharge, study patients were provided
with a scale, pulse oximeter, and journal wherein weights and
saturation levels were recorded daily by parents. Thirteen of
24 patients were found to have a decrease in saturation level
or failure to gain weight; these patients underwent S2R at
a median of 3.7 months versus 5.2 months for those with
the usual interstage course. In our cohort, although a signifi-
cant number of patients died after rehospitalization, the most
common scenario was a sudden unexpected death at home. In
roughly half of these cases, either progressive cyanosis or an
identifiable preceding minor illness was found. These symp-
toms, though nonspecific, may be early signs of impending
ISD and require greater attention.2008
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DLimitations
The main limitations of this study relate to its retrospective
nature. Data surrounding ISD events and autopsy reports
were limited or unavailable for some patients, especially
those cared for outside the referral area. During the study
period, evaluation of airway or respiratory complications in
all patients was not standard. The decision to perform bron-
choscopy was at the discretion of the clinician; in general,
only those patients who were especially symptomatic were
referred for evaluation. Therefore, potentially not all patients
with vocal cord paralysis were identified, and it is possible we
may have missed more subtle vocal cord disease. In addition,
small numbers of patients with specific risk factors limit the
predictive power of this analysis.
Conclusions
ISD remains a significant source of mortality in HLHS and its
variants, occurring in 10.5% of patients surviving to hospital
discharge. Patients with an intact or highly restrictive atrial
septum and those undergoing S1R at greater than 7 days of
life are at significantly higher risk for ISD. In addition, the
presence of a postoperative arrhythmia or postoperative
airway or respiratory complication is associated with a greater
risk of ISD in univariate analysis. The causes of ISD are mul-
tiple, and it is unlikely that a single surgical or medical inter-
vention will significantly improve the incidence of ISD. The
results of this study provide a foundation for prospective
interstage surveillance focused on minimizing ISD and
improving overall outcomes in patients with single ventricle.
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D368 S1R 
313 S1R survivors (85 )
5 transplanted (1.6 ) 33 ISD (10.5 ) 12 inoperable (4 )
263 underwent S2R (71 )
99 controls1
Figure E1. Patient population. Five patients were
lost to follow-up after S1R; S1R, Stage 1 recon-
struction; ISD, interstage death; S2R, stage 2 re-
construction.1 Controls were randomly selected
(3 for each case from within operative year of
case) from the cohort of patients surviving to S2R.99.e1 The Journal of Thoracic and Cardiovascular Surgery c July 2008
Hehir et al Surgery for Congenital Heart DiseaseTABLE E1. Results of available autopsies
Patient Autopsy results
2 Old and new infarctions of the anterior papillary muscle of the tricuspid valve
11 Subendocardial and myocardial infarction and hemorrhage consistent with myocardial infarction
15 Nondiagnostic; right ventricular hypertrophy; small subdural hemorrhage
18 Shunt occlusion with septic thrombus
20 Severe cardiomegaly and right ventricular hypertrophy; residual coarctation 4 mm
21 Multiple systemic emboli and thromboses including pulmonary and renal
27 Hemorrhage and infarction of papillary muscle; residual coarctation 4 mm
31 Polymicrobial sepsis; possible bowel infarctionCH
D
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DAPPENDIX E1. Abbreviations and Acronyms
AA Aortic atresia
AS Aortic stenosis
AV Atrioventricular
AVC Atrioventricular canal
BTS Blalock–Taussig shunt
C. diff Clostridium difficile
CPB Cardiopulmonary bypass
CRI Chronic respiratory insufficiency
DHCA Deep hypothermic circulatory arrest
DORV Double-outlet right ventricle
DNR Do Not Resuscitate order
DSC Delayed sternal closure
ECMO Extracorporeal membrane oxygenation
GER Gastroesophageal reflux disease
GT Surgical gastric feeding tube
HLHS Hypoplastic left heart syndrome
IAS Intact or highly restrictive atrial septum
ICU Intensive Care Unit
IRB Institutional review board
ISD Interstage death
LV Left ventricle
MA Mitral atresia
mm Millimeter
MRI Magnetic resonance imaging
MS Mitral stenosis
NG Nasogastric feeding tube
PHTN Pulmonary hypertension
RV–PA Right ventricle to pulmonary artery shunt
S1R Stage 1 reconstruction
S2R Stage 2 reconstruction
TGA Transposition of the great arteries
TR Tricuspid regurgitation
URI Upper respiratory infection
VCP Vocal cord paresis99.e3 The Journal of Thoracic and Cardiovascular Surgery c July 2008
